72 related articles for article (PubMed ID: 24450768)
21. The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity.
Gorski JC; Vannaprasaht S; Hamman MA; Ambrosius WT; Bruce MA; Haehner-Daniels B; Hall SD
Clin Pharmacol Ther; 2003 Sep; 74(3):275-87. PubMed ID: 12966371
[TBL] [Abstract][Full Text] [Related]
22. Dietary regulation of mouse intestinal P450 expression and drug metabolism.
Zhang P; Jia K; Fang C; Zhou X; Ding X; Zhang QY
Drug Metab Dispos; 2013 Feb; 41(2):529-35. PubMed ID: 23160819
[TBL] [Abstract][Full Text] [Related]
23. The role of renal proximal tubule P450 enzymes in chloroform-induced nephrotoxicity: utility of renal specific P450 reductase knockout mouse models.
Liu S; Yao Y; Lu S; Aldous K; Ding X; Mei C; Gu J
Toxicol Appl Pharmacol; 2013 Oct; 272(1):230-7. PubMed ID: 23732084
[TBL] [Abstract][Full Text] [Related]
24. Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis.
Kharasch ED; Walker A; Hoffer C; Sheffels P
Clin Pharmacol Ther; 2004 Nov; 76(5):452-66. PubMed ID: 15536460
[TBL] [Abstract][Full Text] [Related]
25. The effect of oral pleconaril on hepatic cytochrome P450 3A activity in healthy adults using intravenous midazolam as a probe.
Ma JD; Nafziger AN; Rhodes G; Liu S; Gartung AM; Bertino JS
J Clin Pharmacol; 2006 Jan; 46(1):103-8. PubMed ID: 16397289
[TBL] [Abstract][Full Text] [Related]
26. Oral midazolam-grapefruit juice drug interaction.
Goho C
Pediatr Dent; 2001; 23(4):365-6. PubMed ID: 11572503
[TBL] [Abstract][Full Text] [Related]
27. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P
Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316
[TBL] [Abstract][Full Text] [Related]
28. Effect of atorvastatin and fluvastatin on the metabolism of midazolam by cytochrome P450 in vitro.
Mc Donnell CG; Shorten G; Van Pelt FN
Anaesthesia; 2005 Aug; 60(8):747-53. PubMed ID: 16029222
[TBL] [Abstract][Full Text] [Related]
29. Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: effect of ketoconazole.
Tsunoda SM; Velez RL; von Moltke LL; Greenblatt DJ
Clin Pharmacol Ther; 1999 Nov; 66(5):461-71. PubMed ID: 10579473
[TBL] [Abstract][Full Text] [Related]
30. The glucocorticoid receptor is essential for induction of cytochrome P-4502B by steroids but not for drug or steroid induction of CYP3A or P-450 reductase in mouse liver.
Schuetz EG; Schmid W; Schutz G; Brimer C; Yasuda K; Kamataki T; Bornheim L; Myles K; Cole TJ
Drug Metab Dispos; 2000 Mar; 28(3):268-78. PubMed ID: 10681370
[TBL] [Abstract][Full Text] [Related]
31. Knockout of hepatic P450 reductase aggravates triptolide-induced toxicity.
Xue X; Gong L; Qi X; Wu Y; Xing G; Yao J; Luan Y; Xiao Y; Li Y; Wu X; Chen M; Gu J; Ren J
Toxicol Lett; 2011 Aug; 205(1):47-54. PubMed ID: 21596114
[TBL] [Abstract][Full Text] [Related]
32. Application of semisimultaneous midazolam administration for hepatic and intestinal cytochrome P450 3A phenotyping.
Lee JI; Chaves-Gnecco D; Amico JA; Kroboth PD; Wilson JW; Frye RF
Clin Pharmacol Ther; 2002 Dec; 72(6):718-28. PubMed ID: 12496753
[TBL] [Abstract][Full Text] [Related]
33. The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.
Wang Z; Gorski JC; Hamman MA; Huang SM; Lesko LJ; Hall SD
Clin Pharmacol Ther; 2001 Oct; 70(4):317-26. PubMed ID: 11673747
[TBL] [Abstract][Full Text] [Related]
34. A phase I study of docetaxel with ketoconazole modulation in patients with advanced cancers.
Yong WP; Wang LZ; Tham LS; Wong CI; Lee SC; Soo R; Sukri N; Lee HS; Goh BC
Cancer Chemother Pharmacol; 2008 Jul; 62(2):243-51. PubMed ID: 17909805
[TBL] [Abstract][Full Text] [Related]
35. The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo.
Gorski JC; Huang SM; Pinto A; Hamman MA; Hilligoss JK; Zaheer NA; Desai M; Miller M; Hall SD
Clin Pharmacol Ther; 2004 Jan; 75(1):89-100. PubMed ID: 14749695
[TBL] [Abstract][Full Text] [Related]
36. Role of hepatic cytochrome P450 enzymes in the detoxication of aristolochic acid I; effects on DNA adduct, mutation, and tumor formation.
Luan Y; Xing G; Ren J; Gu J
Genes Environ; 2015; 37():11. PubMed ID: 27350808
[TBL] [Abstract][Full Text] [Related]
37. Kinetics of trihalogenated acetic acid metabolism and isoform specificity in liver microsomes.
Saghir SA; Ghanayem BI; Schultz IR
Int J Toxicol; 2011 Oct; 30(5):551-61. PubMed ID: 21933969
[TBL] [Abstract][Full Text] [Related]
38. The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin.
Gorski JC; Jones DR; Haehner-Daniels BD; Hamman MA; O'Mara EM; Hall SD
Clin Pharmacol Ther; 1998 Aug; 64(2):133-43. PubMed ID: 9728893
[TBL] [Abstract][Full Text] [Related]
39. Effects of Phyllanthus amarus on the pharmacokinetics of midazolam and cytochrome P450 activities in rats.
Taesotikul T; Nakajima M; Tassaneeyakul W; Yokoi T
Xenobiotica; 2012 Jul; 42(7):641-8. PubMed ID: 22339466
[TBL] [Abstract][Full Text] [Related]
40. A novel incubation direct injection LC/MS/MS technique for in vitro drug metabolism screening studies involving the CYP 2D6 and the CYP 3A4 isozymes.
Bhoopathy S; Xin B; Unger SE; Karnes HT
J Pharm Biomed Anal; 2005 Apr; 37(4):739-49. PubMed ID: 15797796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
